Full Text View
Tabular View
No Study Results Posted
Related Studies
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
This study has been completed.
Study NCT00550628   Information provided by Memorial Sloan-Kettering Cancer Center

First Received on October 25, 2007.   Last Updated on February 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Additional conditions recognized in this trial
Colonic Neoplasms
Colorectal Neoplasms
Neoplasms
Precancerous Conditions
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
DNA methylation analysis
fluorescence in situ hybridization
gene expression analysis
polymerase chain reaction
protein expression analysis
immunoenzyme technique
biopsy
therapeutic conventional surgery
fludeoxyglucose F 18
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services